atovaquone has been researched along with Leishmaniasis, Visceral in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camara, L; Queirós, J; Ribeiro, R; Teófilo, E | 1 |
| Astier, A; Cauchetier, E; Deniau, M; Fessi, H; Paul, M; Rivollet, D | 2 |
| Hariprashad, J; Murray, HW | 1 |
| Gibbs, D; Goyal, A; Kumar, P; Makharia, M; Murray, H; Rogers, M; Sundar, S | 1 |
1 trial(s) available for atovaquone and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Atovaquone alone or with fluconazole as oral therapy for Indian kala-azar.
Topics: Adolescent; Adult; Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Child; Child, Preschool; Drug Therapy, Combination; Female; Fluconazole; Humans; Leishmaniasis, Visceral; Male; Middle Aged; Naphthoquinones; Pilot Projects | 1998 |
4 other study(ies) available for atovaquone and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Meglumine antimoniate combination treatment for relapsing Kala-azar after treatment and secondary prophylaxis failure with liposomal amphotericin B in two HIV-coinfected patients.
Topics: Adult; Amphotericin B; Atovaquone; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Middle Aged; Recurrence; Secondary Prevention; Treatment Outcome | 2019 |
Therapeutic evaluation of free and nanocapsule-encapsulated atovaquone in the treatment of murine visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Biocompatible Materials; Capsules; Dose-Response Relationship, Drug; Drug Compounding; Leishmania infantum; Leishmaniasis, Visceral; Liver; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron; Naphthoquinones; Polyesters | 2003 |
Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis.
Topics: Administration, Oral; Animals; Antimony; Antiprotozoal Agents; Atovaquone; Drug Combinations; Female; Leishmania donovani; Leishmaniasis, Visceral; Liver; Mice; Mice, Inbred BALB C; Naphthoquinones; Rats | 1996 |
Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Body Weight; Drug Compounding; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Liver; Male; Mice; Mice, Inbred BALB C; Naphthoquinones; Spleen | 2000 |